Scleroderma

Key Points

• Scleroderma is a chronic autoimmune disorder marked by inflammation and excess collagen deposition.
• Disease may be localized to skin structures or systemic with vascular and major-organ involvement.
• Raynaud phenomenon, skin thickening, and swallowing difficulty are common early systemic cues.
• Progressive systemic disease can affect lungs, heart, kidneys, and GI tract, creating high-risk complications.
• Nursing priorities are early recognition, trend-based organ monitoring, and urgent escalation of renal or cardiopulmonary deterioration.
• There is no known cure; care focuses on symptom control, complication prevention, and multidisciplinary long-term monitoring.

Pathophysiology

Scleroderma (systemic sclerosis) is an autoimmune connective-tissue disease in which immune dysregulation drives inflammation and excessive collagen formation. The resulting fibrosis causes thickening and tightening of skin and connective tissues.

When disease extends beyond the skin, vascular dysfunction and fibrosis can impair organ function in cardiopulmonary, renal, and gastrointestinal systems.

Classification

• Localized scleroderma: Skin-focused disease with limited deeper involvement.
• Morphea: Patch-like localized lesions.
• Linear scleroderma: Linear band pattern across limb or facial/forehead regions.
• Systemic scleroderma: Skin plus vascular/organ involvement.
• Limited systemic type: Gradual onset, often face/hands/feet predominant with early Raynaud pattern.
• Diffuse systemic type: Broader/faster skin progression with higher major-organ involvement risk.

Nursing Assessment

NCLEX Focus

Prioritize cardiopulmonary, renal, and swallowing risk while tracking progression of skin and vascular findings.

• Assess skin pattern (patches/lines), thickening, tightening, and progression distribution.
• Screen for Raynaud phenomenon (white/blue finger or toe color change with cold or stress).
• Review risk context including first-degree family history pattern, sex/hormonal factors, and relevant immune-inflammatory exposure history.
• Assess for dysphagia, reflux/heartburn, bloating, diarrhea, constipation, and fecal incontinence.
• Monitor for dyspnea, activity intolerance, hypertension, irregular pulse, edema, and fatigue.
• Screen for telangiectasia and calcific skin nodules, especially in hands/face.
• Evaluate functional effects, including joint stiffness, restricted movement, muscle weakness, and pain.
• Treat abrupt BP elevation as urgent because renal crisis can progress rapidly to kidney failure.

Nursing Interventions

• Document lesion type, body distribution, progression rate, and associated vascular/GI/cardiopulmonary findings.
• Reinforce cold-protection and stress-reduction measures for Raynaud-trigger reduction.
• Coordinate timely specialty referral and diagnostics when systemic involvement is suspected.
• Reinforce that treatment goals are symptom control and complication prevention, not cure, and support long-term follow-up adherence.
• Escalate sudden hypertension, worsening dyspnea, or rapidly progressive dysphagia immediately.
• Support nutrition and swallowing safety planning when GI/esophageal involvement reduces intake tolerance.
• Coordinate multidisciplinary care planning with rheumatology, dermatology, pulmonology, and other organ-specific teams as indicated.

Renal Crisis Risk

Sudden severe blood-pressure increase in systemic scleroderma requires emergent evaluation to prevent acute kidney failure.

Pharmacology

Drug Class	Examples	Key Nursing Considerations
Condition-directed specialist therapy	Protocol-specific	Regimens vary by organ involvement; monitor symptom trends, BP, and tolerance closely.
Supportive symptom-control therapy	Protocol-specific	Coordinate skin, vascular, GI, and cardiopulmonary symptom management with interprofessional teams.

Clinical Judgment Application

Clinical Scenario

A patient with progressive skin tightening reports new severe reflux, finger color changes in cold environments, and rising blood-pressure readings.

• Recognize Cues: Multisystem progression with vascular and GI involvement plus renal-risk signal.
• Analyze Cues: Findings suggest systemic rather than localized disease burden.
• Prioritize Hypotheses: Immediate concern is renal/cardiopulmonary deterioration.
• Generate Solutions: Escalate urgent BP evaluation, trend organ-risk findings, and coordinate specialty care.
• Take Action: Initiate urgent notification and focused monitoring.
• Evaluate Outcomes: Early intervention reduces risk of irreversible organ injury.

Related Concepts

• immune-system - Autoimmune dysregulation context for connective-tissue injury.
• rheumatoid-arthritis-autoimmune-joint-disease - Comparative autoimmune rheumatic disease pattern.
• head-and-neck-assessment-and-common-abnormalities - Focused exam cues including facial skin and swallowing changes.
• hypertension-assessment-and-management - Blood-pressure escalation framework relevant to renal-crisis risk.

Self-Check

1. Which findings distinguish localized from systemic scleroderma?
2. Why is sudden hypertension in systemic scleroderma a high-priority emergency cue?
3. How do Raynaud and GI findings influence ongoing nursing monitoring priorities?